Web Analytics
ANIK (NASDAQ) 株価分析 | ANIKA THERAPEUTICS INC – Deepscope
MARKET

Select Market Data Region

ANIK 株価分析 — Anika Therapeutics Inc (Healthcare >> Drug Manufacturers - Specialty & Generic)

ANIK に関するよくある質問

ANIKのPER(株価収益率)は?

Anika Therapeutics Inc(ANIK)は現在PER 77.06倍で取引されています。

ANIKのROE(自己資本利益率)は?

Anika Therapeutics IncのROEは-2.76%です。

ANIKの配当利回りは?

Anika Therapeutics Incの配当利回りは0.00%です。

ANIKの品質スコア(Quality Score)は?

当社のAIはANIKの総合財務品質を100点中54点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

ANIKは今が買い時ですか?

当社AIのタイミングスコアは100点中91点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

ANIKはどのセクターに属しますか?

Anika Therapeutics IncはHealthcare >> Drug Manufacturers - Specialty & Genericセクターに分類されます(NASDAQ市場)

Stock Check   *Daily update data at 8:30 AM*
(Price: 2026-08-04 | FS: 2026-06-30)

ANIK AI Analysis Summary

Our AI summary for ANIK: Anika Therapeutics Inc (NASDAQ), Healthcare >> Drug Manufacturers - Specialty & Generic sector. The stock currently trades at a P/E of 77.06, ROE of -2.76%, a dividend yield of 0.00%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

ANIK

Anika Therapeutics Inc
USD 19.61
-1.13 (-5.43%) Day Change
77.06
P/E
0.34
D/E
-2.8%
ROE
-2.1%
ROA
0.00%
Div Yield
0.68
PEG
USD 19.61
Price
-1.13 (-5.43%)
Day Change
NEWS SCORE: 99

ANIK, ファンダメンタルスコアはnot quite good ( ファンダメンタル = 54) but テクニカルスコアは ...(Sign In to See)...

54

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
P/Eが高い。割高銘柄。
ROEが低い
ROAが低い
平均ROEが低い
ROAがROEに比べて低い
NPMが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Momentum indicators aligned on the daily timeframe
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...

Deepscope 分析 45%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 99
  Magic Formula Rank by ROA
N/A
  Magic Formula Rank by ROE
N/A
  Magic Formula Rank by ROIC
N/A
  Price 19.61
  PBV / Sector
2.02 / 10.04
  Earning Per Share -0.27
  PE / Sector
77.06 / 32.60
  PEG or PE/Growth / Sector
0.68 / -0.13
  Average 1M Daily Value
1.51 M
GREAT
  Average 1W Daily Value
3.17 M
GREAT
Timing Factors 85%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Financial Health 45%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
ポイントになる統計 60%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
-3.14 / 12.55
  NPM Average (%) / Sector
-27.55 / -10.76
  NPM Change Average (%) / Sector
110.33 / 113.68
GREAT
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
-2.06 / 7.68
  ROA Average (%) / Sector
-14.08 / 2.97
  ROA Change Average (%) / Sector
116.35 / 111.24
GREAT
  ROE (%) / Sector
-2.76 / 25.75
  ROE Average (%) / Sector
-18.22 / 14.00
  ROE Change Average (%) / Sector
124.88 / 377.43
GREAT
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
配当 4%
X
  Dividend (%) / Sector
N/A / 0.52
  Dividend Average (%) / Sector
N/A / 3.06
  Dividend Change Average (%) / Sector
N/A / 13.76
登録情報
X
  Analyze Date 2026-08-05 07:59:49
  Symbol ANIK
  Name ANIKA THERAPEUTICS INC
  Sector Healthcare >> Drug Manufacturers - Specialty & Generic
  Market NASDAQ
  Listed Shares 13.38 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 277.50 / 10,527.15
ニュース
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: 32 Wiggins Avenue, Bedford, MA, United States, 01730

Phone: 781 457 9000

Website: https://www.anika.com

Employees: 235

Sector: Healthcare >> Drug Manufacturers - Specialty & Generic

Description: Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-opioid, single-injection OA pain management product; regenerative solutions, including an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; Hyalofast, a resorbable scaffold used for single stage cartilage regeneration; and Tactoset injectable bone substitute, an HA-enhanced injectable bone repair therapy designed to treat insufficiency fractures and augment hardware fixation. It also provides Integrity, an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; non-orthopedic products, including Hyvisc, a high molecular weight injectable HA veterinary product for the treatment of joint dysfunction in horses due to non-infectious synovitis associated with equine OA; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and ophthalmic products; and Anikavisc and Nuvisc high molecular weight HA products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.

Analyst Ratings & Target Price

3 Months Ago
1 Month Ago
Current
Strong Buy
2
2
2
Buy
1
1
1
Hold
0
0
0
Sell
0
0
0
Strong Sell
0
0
0
Consensus
Strong Buy 4.67
Strong Buy 4.67
Strong Buy 4.67
Target Price
USD 17.50
USD 17.50
USD 21.00

Per-Share Earnings, Estimates vs Actuals

Actual
Analyst Range
Estimate

ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic

ANIK (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

同業種の銘柄

Healthcare › Drug Manufacturers - Specialty & Generic

同じ基準で分析・時価総額順

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
ANIK
ANIK
USD 19.61 (-5.43%)
+ Watch + Port Chart